Financial reports
10-Q
2011 Q3
Quarterly report
14 Nov 11
10-Q
2011 Q2
Quarterly report
15 Aug 11
10-Q
2011 Q1
Quarterly report
16 May 11
10-K
2010 FY
Annual report
30 Mar 11
10-Q
2010 Q3
Quarterly report
12 Nov 10
10-Q
2010 Q2
Quarterly report
13 Aug 10
10-Q
2010 Q1
Quarterly report
14 May 10
10-K
2009 FY
Annual report
29 Mar 10
10-Q
2009 Q3
Quarterly report
13 Nov 09
10-Q
2009 Q2
Quarterly report
13 Aug 09
Current reports
8-K
Departure of Directors or Certain Officers
16 Jan 13
8-K
Unregistered Sales of Equity Securities
20 Jan 12
8-K
Entry into a Material Definitive Agreement
18 May 11
8-K
Other Events
17 Oct 07
8-K
Departure of Directors or Principal Officers
25 Jun 07
8-K
Human Pheromone Sciences Announces License Agreement
22 Aug 06
8-K
Other Events
21 Nov 05
8-K
Other Events
30 Sep 05
8-K
Other events
4 Jun 03
8-K
Acquisition or disposition of assets
29 Apr 03
Registration and prospectus
Proxies
DEF 14A
Definitive proxy
29 Apr 09
DEF 14A
Definitive proxy
29 Apr 08
DEF 14A
Definitive proxy
30 Apr 07
DEF 14A
Definitive proxy
28 Apr 06
DEF 14A
Definitive proxy
29 Apr 05
DEF 14A
Definitive proxy
29 Apr 04
DEF 14A
Definitive proxy
30 Apr 03
DEFR14A
Revised proxy
10 Jul 02
PRE 14A
Preliminary proxy
21 Jun 02
DEF 14A
Definitive proxy
30 Apr 02
Other
UPLOAD
Letter from SEC
26 Mar 08
CORRESP
Correspondence with SEC
21 Mar 08
UPLOAD
Letter from SEC
26 Feb 08
CORRESP
Correspondence with SEC
15 Feb 08
UPLOAD
Letter from SEC
24 Jan 08
CORRESP
Correspondence with SEC
22 Jan 08
UPLOAD
Letter from SEC
21 Dec 07
UPLOAD
Letter from SEC
9 May 05
CORRESP
Correspondence with SEC
5 May 05
UPLOAD
Letter from SEC
22 Apr 05